BACKGROUND	We aimed to evaluate whether 3-month use of cilostazol in addition to dual antiplatelet therapy ( DAPT ) improved clinical outcomes in patients with long or multivessel coronary artery disease ( CAD ) after biolimus-eluting stent ( BES ) implantation .\